Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GPO Initiative attracts Senate support

This article was originally published in The Gray Sheet

Executive Summary

Senate Judiciary Committee members Jon Kyl (R-Ariz.), Chuck Schumer (D-N.Y.), Ted Kennedy (D-Mass.), Sam Brownback (R-Kan.) and John Cornyn (R-Texas) endorse the Healthcare Group Purchasing Industry Initiative, with nine GPOs participating. Statements from some of the senators appear in a July 12 release issued by Premier, key coordinator of the effort to self-regulate GPO business practices. The Medical Device Manufacturers Association responds with a July 13 release arguing the Initiative will not adequately regulate GPO practices because the plan lacks a uniform contracting mechanism, independent oversight, penalties for non-compliance and a remedy for "excess fees" collected by GPOs. Senatorial backing of the Initiative, however, may dissuade the Antitrust Subcommittee from re-introducing GPO legislation (1"The Gray Sheet" May 23, 2005, p. 16)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022396

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel